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Abstract
Background: Measures of premature mortality have been used to guide debates on future health priorities and to
monitor the population health status. Standard expected years of life lost (SEYLL) is one of the methods used to
assess the time lost due to premature death. This article affords an overview of premature mortality in Spain for
the year 2008.
Methods: A population-based study was conducted estimating SEYLL by sex and age groups. SEYLL, a key
component of the disability-adjusted life years measure of disease burden, was calculated using Princeton West
standard life tables with life expectancy at birth fixed at 80 years for males and 82.5 years for females. Population
data and specific death records were obtained from the official registers of the National Institute of Statistics. All
data were analysed and prepared in GesMor and Epidat software packages.
Results: The burden of premature mortality was estimated at 2.1 million SEYLL when age at death is taken into
account. Males lost 60.9% and females lost 39.1% of total SEYLL. Malignant tumors (34.5%) and cardiovascular
diseases (24.0%) were the leading categories in terms of SEYLL. Ischaemic heart disease (8.5%) and lung cancers
(8.0%) were the most common specific causes of SEYLL followed by cerebrovascular diseases (5.9%), colorectal
cancer (4.1%), road traffic accidents (3.5%), Alzheimer and other dementias (2.9%), chronic obstructive pulmonary
disease (2.8%), breast cancer (2.8%) and suicides (2.6%).
Conclusions: In Spain, premature mortality was essentially due to chronic non-communicable diseases. Data
provided in this study are relevant for a more balanced health agenda aimed at reducing the burden of premature
mortality. This study also represents a first step in estimating the overall burden of disease in terms of premature
death and disability.
Background
Historically, mortality rates have been used to compare
health status across populations. These measures do not
fully account for the burden of premature mortality, an
important indicator of a population health status. In
fact, since most deaths occur among persons in older
age groups, mortality rates are dominated by the under-
lying disease processes of the elderly [1]. Premature
mortality entails estimating the average time a person
would have lived had he or she not died prematurely.
This estimation inherently incorporates age at death,
rather than merely the occurrence of death itself [2].
In recent years, considerable efforts have been put into
the development of summary measures of population
health that combine information on mortality and non-
fatal health outcomes. In the Global Burden of Disease
study [3,4], a standardized form of years of life lost for
measuring the burden of disease due to premature mortal-
ity was promoted. Particularly, the standard expected
years of life lost (SEYLL) method was adopted to take into
account the age at which deaths occur by giving greater
weight to deaths occurring at younger ages and lower
weight to deaths occurring at older ages. For several
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measure of the burden of premature mortality, including:
deaths at all ages contribute to the calculation of the bur-
den of disease irrespective of the population in which they
occur (in contrast with alternative approaches that use a
fixed cut-off age e.g., 0-65, 0-75, or 1-70 years), as wells as
deaths at the same age contribute equally to the burden of
disease [5].
Health policy-makers face the challenge of responding
to current disease prevention and control priorities, while
being responsible for predicting future priorities. Ideally,
such decisions should be based on summary measures of
population health [6,7], including premature mortality.
Summary measures are intended to guide debates on
future health priorities, and they provide a way of moni-
toring and evaluating changes in the population health
and the potential benefits of healthcare services [7].
In this context, the present article affords a detailed
overview of the burden of premature mortality in Spain
for the year 2008 by using SEYLL.
Methods
The methods used are directly derived from those devel-
oped by Murray and Lopez in the Global Burden of
Disease study [3]. We followed this methodology to quan-
tify the magnitude and distribution of premature mortality
in the Spanish population, by estimating SEYLL, one of
the two components that summarize disability-adjusted
life years (DALY), by cause, sex and age group for the year
2008. Following the disease burden classification system,
diseases and injuries were presented into 3 broad groups:
communicable diseases and maternal, perinatal and nutri-
tional disorders (group I); chronic non-communicable dis-
eases (group II); and all injuries (group III). These groups
are divided into 21 major categories which can be disag-
gregated into approximately 100 subcategories.
SEYLL measure correspond to the number of unlived
years in a population as a consequence of premature
mortality and are calculated from the number of deaths
multiplied by a standard life expectancy at the age at
which death occurs. The formula for calculating SEYLL
for a given cause is: SEYLL = KCe
ra/(r+b)
2[e
-( r+b)(L+a)
[-(r+b)(L+a)-1] -e
-(r + b)a[-(r+b)a-1]]+(1-K)/r(1-e
-rL),
where: r: discount rate (for health gains in the future);
K: standard age-weighting modulation factor, a para-
meter that allows nonuniform (K = 1) age weighting to
be used; C = constant = 0.1658; b = parameter from the
age weighting function = 0.04; L = years of life left at
age a; a = onset of disease year; e = constant = 2.71.
Data, both on the number of deaths by sex, age and
specific causes and on the population for 2008 were
obtained from the official registers of the National Insti-
tute of Statistics (Instituto Nacional de Estadística,I N E )
[8,9]. Individuals residing and dying of Spain in 2008
were considered in our analyses, with a mid-year popu-
lation of 45,593,385 (22,512,354 males and 23,081,031
females). Anonymised death records are based on death
certificates completed shortly after the time of death
and are coded according to the International Classifica-
tion of Diseases, 10
th Revision (ICD-10 codes). We
applied a mortality standard norm based on a model life
table (namely, Princeton West level 26 modified) which
has a life expectancy at birth of 80 years for males and
82.5 years for females [9,10]. We used this standard life
expectancy because is the same for deaths in all regions
of the world and is the same as that used for the calcu-
lation of DALY measures. Additionally, social values
were incorporated to the calculation of SEYLL, includ-
ing 3% time discounting and non-uniform age weights
that give less weight to years lived at early and older
ages were used. We also followed the general approach
proposed by Murray and Lopez to reclassify diagnoses
for the ill-defined causes of death when needed.
All data were analysed and prepared in GesMor (Insti-
tuto de Salud Carlos III, Madrid, Spain) [11] and Epidat
4.0 (Consellería de Sanidade, Xunta de Galicia, Spain
and Pan American Health Organization, Washington
D.C., USA) [12] software packages.
Results
In Spain, the burden of premature mortality was esti-
mated as a total of 2,099,291 SEYLL (39.1 per cent of
them in females) in 2008, with SEYLL rates per 1,000
Spanish people of 46.0 (56.8 for males and 35.6 for
females). Overall, chronic non-communicable diseases
(group II) accounted for 83.4 per cent of the total num-
ber of SEYLL (87.7 per cent in females), accidents and
injuries (group III) for 10.1 per cent (2.1 per cent in
females), and communicable, maternal, perinatal, and
nutritional conditions (group I) accounted the remaining
6.5 per cent (Table 1).
Malignant tumors, which account for 34.5 per cent of
the total SEYLL, are the major cause of premature mor-
tality in Spain for 2008 (Table 2), followed by cardiovas-
cular diseases (24.0 per cent) and unintentional injuries
(7.1 per cent). These three disease categories account
for 65.6 per cent of the total SEYLL lost in the Spanish
population. Respiratory diseases (6.2 per cent), digestive
diseases (5.6 per cent) and mental and neurological dis-
orders (5.6 per cent) rank fourth, fifth and sixth,
respectively.
Table 3 depicts the leading specific subcategories that
caused most SEYLL. Ischaemic heart disease (8.5 per
cent) and lung cancer (8.0 per cent) ranked first and sec-
ond respectively, followed by cerebrovascular disease
(5.9 per cent), colorectal cancer (4.1 per cent), road traffic
accidents (3.5 per cent), Alzheimer and other dementias
(2.9 per cent), chronic obstructive pulmonary disease
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Page 2 of 9(2.8 per cent), breast cancer (2.8 per cent) and suicides
(2.6 per cent). Calculating SEYLLs by sex revealed males
and females variations in the burden of premature mor-
tality. The ranking of the leading disease categories and
specific causes in terms of premature deaths was different
for both sexes. Lung cancer (10.8 per cent) ranked first in
males, followed by ischaemic heart disease (9.7 per cent),
cerebrovascular disease (4.9 per cent) and road traffic
accidents (4.6 per cent). In females, cerebrovascular dis-
ease (7.5 per cent) and breast cancer (7.1 per cent) were
the first and second leading causes of SEYLL respectively,
followed by ischaemic heart disease (6.7 per cent) and
Alzheimer and other dementias (4.7 per cent). Figure 1
shows the distribution of SEYLL rates (per 1,000 people)
attributable to each of the leading disease conditions by
sex and age group.
In terms of age, 39.8 per cent of the burden of prema-
ture mortality was concentrated in subjects aged over 70
years old, with the general trend being for SEYLL to rise
with age (Table 4). Figure 2 shows the SEYLL rates (per
1,000 people) by sex and age group. A breakdown by
subcategory revealed perinatal conditions (48.5 per cent)
and congenital anomalies (25.3 per cent) as being
important in the 0-4 years age group, and unintentional
injuries (23.8 per cent), malignant tumors (22.2 per
cent) and neurological and mental disorders (11.4 per
cent) in the 5-14 years age group. Between the ages of
15 and 29 years, unintentional injuries continued as the
Table 1 Standard expected life years lost (SEYLL) by sex and broad cause group. Spain, 2008
Males Females Both sexes
Cause group Number % Rate per 1,000 Number % Rate per 1,000 Number % Rate per 1,000
Group I 82,398 6.4 3.7 53,588 6.5 2.3 135,986 6.5 3.0
Group II 1,030,563 80.6 45.8 720,160 87.7 31.2 1,750,723 83.4 38.4
Group III 164,918 12.9 7.3 47,663 5.8 2.1 212,582 10.1 4.7
Overall 1,277,879 100 56.8 821,412 100 35.6 2,099,291 100 46.0
Group I: Communicable, maternal, perinatal, and nutritional conditions; Group II: Noncommunicable diseases; Group III: Accidents and injuries.
Table 2 Standard expected life years lost (SEYLL) by sex and cause categories. Spain, 2008
Males Females Both
sexes
Cause categories Number % Rank Rate per
1,000
Number % Rank Rate per
1,000
Number % Rank Rate per
1,000
Malignant tumors 445,321 34.8 1 19.8 278,056 33.9 1 12.0 723,377 34.5 1 15.9
Cardiovascular diseases 289,506 22.7 2 12.9 214,585 26.1 2 9.3 504,091 24.0 2 11.1
Unintentional injuries 115,913 9.1 3 5.1 33,018 4.0 6 1.4 148,931 7.1 3 3.3
Respiratory diseases 85,763 6.7 4 3.8 44,307 5.4 4 1.9 130,071 6.2 4 2.9
Digestive diseases 76,276 6.0 5 3.4 41,339 5.0 5 1.8 117,615 5.6 5 2.6
Mental and neurological
conditions
55,029 4.3 6 2.4 62,261 7.6 3 2.7 117,290 5.6 6 2.6
Infectious and parasitic
diseases
41,303 3.2 8 1.8 22,552 2.7 7 1.0 63,855 3.0 7 1.4
Intentional injuries 49,005 3.8 7 2.2 14,645 1.8 11 0.6 63,651 3.0 8 1.4
Diabetes mellitus 19,466 1.5 10 0.9 20,146 2.5 8 0.9 39,612 1.9 9 0.9
Respiratory infections 21,257 1.7 9 0.9 15,050 1.8 10 0.7 36,307 1.7 10 0.8
Genitourinary diseases 18,497 1.4 12 0.8 17,001 2.1 9 0.7 35,498 1.7 11 0.8
Perinatal conditions 19,295 1.5 11 0.9 14,575 1.8 12 0.6 33,870 1.6 12 0.7
Congenital anomalies 13,473 1.1 13 0.6 12,131 1.5 13 0.5 25,604 1.2 13 0.6
Endocrine and blood
disorders
10,892 0.9 14 0.5 11,009 1.3 14 0.5 21,901 1.0 14 0.5
Other (benign) tumors 10,681 0.8 15 0.5 9,446 1.1 15 0.4 20,127 1.0 15 0.4
Musculoskeletal diseases 4,260 0.3 16 0.2 7,457 0.9 16 0.3 11,717 0.6 16 0.3
Skin diseases 1,376 0.1 17 0.1 2,387 0.3 17 0.1 3,763 0.2 17 0.1
Nutritional deficiencies 542 0.0 18 0.0 722 0.1 18 0.0 1,264 0.1 18 0.0
Maternal conditions 0 0.0 - 0.0 689 0.1 19 0.0 689 0.0 19 0.0
Oral conditions 19 0.0 19 0.0 32 0.0 20 0.0 51 0.0 20 0.0
Sense organ diseases 4 0.0 20 0.0 3 0.0 21 0.0 7 0.0 21 0.0
Overall 1,277,879 100 56.8 821,412 100 35.6 2,099,291 100 46.0
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Page 3 of 9Table 3 Standard expected life years lost (SEYLL) by sex and leading specific subcategories. Spain, 2008
Males Females Both
sexes
Specific subcategories Number % Rank Rate per
1,000
Number % Rank Rate per
1,000
Number % Rank Rate per
1,000
Ischaemic heart disease 124,257 9.7 2 5.5 55,176 6.7 3 2.4 179,433 8.5 1 3.9
Lung cancer 138,406 10.8 1 6.1 30,283 3.7 6 1.3 168,690 8.0 2 3.7
Cerebrovascular disease 62,601 4.9 3 2.8 61,215 7.5 1 2.7 123,816 5.9 3 2.7
Colorectal cancer 50,190 3.9 5 2.2 36,261 4.4 5 1.6 86,451 4.1 4 1.9
Road traffic accidents 59,333 4.6 4 2.6 13,708 1.7 12 0.6 73,041 3.5 5 1.6
Alzheimer and other dementias 20,958 1.6 14 0.9 39,001 4.7 4 1.7 59,959 2.9 6 1.3
Chronic obstructive pulmonary disease (COPD) 46,284 3.6 6 2.1 12,765 1.6 14 0.6 59,049 2.8 7 1.3
Breast cancer 498 0.0 - 0.0 58,413 7.1 2 2.5 58,911 2.8 8 1.3
Suicides 43,391 3.4 7 1.9 12,191 1.5 15 0.5 55,581 2.6 9 1.2
Cirrhosis of the liver 36,062 2.8 8 1.6 11,742 1.4 17 0.5 47,804 2.3 10 1.0
Stomach cancer 25,233 2.0 9 1.1 14,470 1.8 10 0.6 39,703 1.9 11 0.9
Pancreas cancer 22,133 1.7 11 1.0 16,379 2.0 8 0.7 38,512 1.8 12 0.8
Lower respiratory infections 21,093 1.7 13 0.9 14,837 1.8 9 0.6 35,930 1.7 13 0.8
Liver cancer 23,918 1.9 10 1.1 9,000 1.1 22 0.4 32,917 1.6 14 0.7
Lymphomas and multiple myeloma 18,518 1.4 18 0.8 14,344 1.7 11 0.6 32,861 1.6 15 0.7
Inflammatory heart diseases 19,570 1.5 16 0.9 12,132 1.5 16 0.5 31,702 1.5 16 0.7
Brain cancer 16,898 1.3 20 0.8 11,440 1.4 18 0.5 28,338 1.3 17 0.6
Leukaemias 14,516 1.1 22 0.6 10,593 1.3 20 0.5 25,110 1.2 18 0.6
Human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS)
19,085 1.5 17 0.8 5,861 0.7 24 0.3 24,946 1.2 19 0.5
Bladder cancer 20,789 1.6 15 0.9 4,132 0.5 29 0.2 24,922 1.2 20 0.5
Overall 1,277,879 100 56.8 821,412 100 35.6 2,099,291 100 46.0
Note: In males, prostate cancer ranks 12
th (21,633 SEYLL), mouth cancer ranks 19
th (17,386 SEYLL) and poisonings ranks 21
st (16,883 SEYLL). In females, ovarian cancer ranks 7
th (17,026 SEYLL), hypertensive heart
disease ranks 13
th (13,082 SEYLL), and nephritis/nephrosis ranks 19
th (10,968 SEYLL).
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9leading cause of SEYLL (41.8 per cent) followed by
malignant tumors (14.7 per cent), and there was a sharp
rise in intentional injuries (14.0 per cent). In the 30-44
years age group, the premature deaths attributed to
malignant tumors (27.5 per cent), unintentional injuries
(18.7 per cent) and cardiovascular diseases (15.0 per
cent) are worth noting. From 45 to 69 years, malignant
tumors (49.5 per cent) assumed extremely important,
particularly in the case of lung cancer (13.8 per cent),
and cardiovascular diseases (21.0 per cent) such as
ischaemic heart disease began to be relevant (9.2 per
cent). Finally, among subjects aged over 70 years, cardi-
ovascular diseases (33.9 per cent) and malignant tumors
(27.4 per cent) were the first and second leading causes
of SEYLL, respectively.
Detailed information on SEYLL by sex and age group
for all disease and injury categories is given in additional
file 1 ("Detailed information of SEYLL. Spain, 2008”).
Discussion
This study presents an estimation of the burden of pre-
mature mortality for diseases and injuries in Spain,
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Figure 1 Distribution of standard expected life years lost (SEYLL) rates by sex and age group among the leading specific disease
conditions.
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Page 5 of 9largely on the basis of the SEYLL measure as developed
in the Global Burden of Disease study. Our results
clearly indicate the public health relevance of specific
disease conditions and injuries in terms of premature
and avoidable deaths. We estimated the burden of pre-
mature mortality in Spain at 2.1 million SEYLL in 2008.
This figure represents 46.0 years of early deaths were
lost among each 1,000 people. The Spanish male rate of
56.8 years, and female rate of 35.6 years per 1,000 popu-
lation in 2008 compare well with other developed coun-
tries [4]. In the country, the leading causes of death
when age at death is taken into account through SEYLL
were chronic non-communicable diseases. Similarly, the
greatest number of SEYLL was attributed to malignant
tumors and cardiovascular diseases. In terms of specific
causes, the burden of premature mortality in Spain was
highest for ischaemic heart disease, followed by lung
cancer and cerebrovascular disease, like in other
developed and developing countries [4,13-15] and the
corresponding SEYLL rates were lower even when com-
pared with EURO-A subregion (e.g., 7.3, 3.9 and 3.7 per
1,000 people, respectively) [4]. For the unintentional
injuries subcategory, however, other developed countries
performed better than Spain for both males and females
[4]. This subgroup of injuries include such causes of
death as road traffic accidents, poisonings and accidental
falls, among others.
A coordinated effort by health policy-makers is war-
ranted against premature and preventable death from
chronic non-communicable diseases by supporting pre-
vention, control and rigorous evidence-based medical
technologies and health policy or social programmes in
particular areas. There are many important ways of
achieving a more effective disease management: applying
clinical guidance and consensus, reducing social inequal-
ities by focusing further on the most disadvantaged
Table 4 Standard expected life years lost (SEYLL) by sex and age group. Spain, 2008
Males Females Both sexes
Age group Number % Rate per 1,000 Number % Rate per 1,000 Number % Rate per 1,000
0-4 38,158 3.0 31.0 30,540 3.7 26.3 68,698 3.3 28.7
5-14 10,768 0.8 4.9 7,073 0.9 3.4 17,841 0.8 4.1
15-29 79,649 6.2 17.9 27,982 3.4 6.7 107,631 5.1 12.4
30-44 171,202 13.4 28.8 79,022 9.6 14.0 250,224 11.9 21.6
45-59 320,571 25.1 74.0 148,153 18.0 33.6 468,724 22.3 53.6
60-69 240,286 18.8 118.0 110,362 13.4 49.4 350,648 16.7 82.1
70-79 259,726 20.3 167.3 185,257 22.6 93.5 444,983 21.2 125.9
80+ 157,518 12.3 208.0 233,024 28.4 170.8 390,542 18.6 184.1
Overall 1,277,879 100 56.8 821,412 100 35.6 2,099,291 100 46.0
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Figure 2 Standard expected life years lost (SEYLL) rates by sex and age group. Spain, 2008.
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Page 6 of 9groups (including those with a lower educational level),
reinforcing action on the improvement of lifestyle factors
(e.g., weight loss, alcohol consumption, cigarette smok-
ing, and dietary salt intake), and intensifying the treat-
ment (not only by drug therapies) in patients with
uncontrolled risk factors such as obesity, smoking or
arterial hypertension, among others [16]. In Spain, for
example, the National Quality Plan for the National
Health System [17] has developed health strategies to
ensure highest quality in healthcare services elaborating
national disease control strategies focusing on the most
burdensome conditions in order to guarantee excellence
in healthcare. Such approaches are advocating integrated
focus combining disease prevention and treatment with
the corresponding measures for cancer, ischaemic heart
disease or cerebrovascular disease [18-24]. It is note-
worthy to mention the fact that even though uninten-
tional injuries (including road traffic accidents) are
among the leading causes of SEYLL in Spain, most of the
national research resources allocated have gone to heart
and cancer control programmes in the past [25]. On this
regard, there has been much less attention paid to the
reduction of premature deaths in the injury, with no for-
mal national disease prevention strategy in place.
The analysis presented in this article provide a frame-
work for more detailed analysis of the national burden of
disease, for a baseline against which the impact of the
health status of population in Spain can be evaluated in a
more complete way by means of generalised cost-effec-
tiveness analyses of alternative disease control strategies.
In the same way, previous SEYLL estimates have been
helpful when identifying priority diseases for health
research funding [25,26].
Calculating SEYLL need to have reliable sources of
mortality data. Death records were based on nationwide
registers from the National Institute of Statistics to mea-
sure the number and causes of deaths in the country.
The quality and validity of mortality data depends mostly
of the quality and accuracy of death certification. On this
regard, we used classical algorithms developed in the
Global Burden of Disease study [3,4] for correcting mis-
classification of deaths due to ill-defined causes when
needed. Although local studies of the quality of the
causes of death showed that mortality statistics in Spain
appear to be reasonably reliable for being used for
research and administrative purposes [27,28], recent
interesting proposals for enhancing the algorithms of
national causes of death data could have been included in
our corrections [29,30]. Another of the limitations are the
controversial social values incorporated into the SEYLL.
With regard to the standard life expectancy, we decided
to use a model life table [3,4] because it assigns life
expectancy at all ages and gives consideration to high life
expectancies. As the standard used in most burden of
disease studies providing SEYLL, it also allows for com-
parisons to be made. One can argue for the use of coun-
try-specific life expectancies as an age limit adjusts the
premature mortality calculation to the population profile
of the country or area. However, the problem with this
approach is that the premature mortality will not be
comparable with that of other populations with different
life expectancies.
Another limitation of this study is that the SEYLL mea-
sure we applied is strongly influenced by death rates and
do not provide a full picture of how different disease con-
ditions affect population health [6]. Classical methods of
years of life lost take into account only death at younger
ages and decrease the burden of premature death more if
mortality is lower and occurs at older ages. Given that a
life table standard with a very low mortality (as applied in
the SEYLL method proposed in the Global Burden of
Disease study) increases relatively the burden of mortality
at older ages [31], other summary measures of population
health status such as DALYs and quality-adjusted life
years (QALY) are therefore receiving increasing promi-
nence. These measures combine information not only on
the duration of life, but also on non-fatal disabling out-
comes, and may encompass morbidity, disability and
mortality outcomes in a single metric. Along these lines,
SEYLL reported here represents a first step in estimating
the overall burden of disease in terms of premature death
and disability. Our estimates could be improved in the
future, for example, by collecting incidence and disease
duration data at a national population-level and calculat-
ing the DALY metric.
Conclusions
Calculating SEYLL specifically for Spain provides a sys-
tematic analysis of premature deaths at a population
level and is an important component for identifying dis-
ease areas where greater attention by health policy-
makers is required because they represent preventable
loss of life. Burden of premature mortality in Spain was
fundamentally attributable to chronic non-communic-
able diseases, specifically malignant tumors, cardiovascu-
lar diseases, unintentional injuries, respiratory diseases,
digestive diseases and mental and neurological condi-
tions. We hope the results of this study will lead to a
more balanced health agenda in Spain, with adequate
investment in health research, training activities, and
intervention programs aimed at reducing the burden of
premature mortality.
Additional material
Additional file 1: Detailed information of SEYLL. Spain, 2008.W e
provided detailed tabulations of SEYLL for the disease categories and
specific causes included in Spanish National Burden of Disease study
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